TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07187297: A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Sponsor: Bausch Health Americas, Inc. · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 164 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$954,600

Rescue Site Savings

+$619,200

Unlock Full NCT07187297 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07187297 Rescue Dossier →